Research Insight: Clinical trials have consistently shown that GLP-1 receptor agonists lead to significant delays in gastric emptying, contributing directly to reduced food intake and weight loss
Rose S, Melnyk S, Pavliv O, Bai S, Nick T, Frye R, James S
Chair of RACGP Specific Interests Obesity Management, GP and dietitian Dr Terri-Lynne South says she is pleased the TGA has issued an alert and is raising awareness of a growing number of scams, some of which have been brought to her attention by her own patients
It targets GLP-1, GIP, and GCG receptors, which help regulate appetite and blood sugar levels
Similarly, anxiety, rapid heartbeat, or tremors might suggest over-replacement
Last Updated: November 20th, 2025